biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > $.02

<< Previous

Bullboard Posts

Next >>

Comment by fuzzyjron Mar 01, 2023 10:30am

69 Views

Post# 35312306

RE:$.02

it's nice to see the many possibilities without dishing out personal attacks like some. Much more refreshing looking at the positives that are still possible, believe most here have had more than enough of the negativity related to anything possible or positive. I'm waiting on one or more of the many positive possibilities to hit us via an NR to re-enter this & watch it run for several years.

that's all I'm looking for , the rest is just useless noise.
glta

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale